Results 141 to 150 of about 30,102 (276)
Towards the Development of a Conceptual Framework of the Determinants of Pre‐Eclampsia: A Hierarchical Systematic Review of Social Determinants
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT Background
Existing reviews of pre‐eclampsia determinants have focused on clinical and genetic risk factors. Objective
To evaluate social determinants for pre‐eclampsia prevention. Search Strategy
Systematic searches were conducted from relevant electronic databases from inception of each database to 30th December 2024.Mai‐Lei Woo Kinshella, Kelly Pickerill, Sarina Prasad, Olivia Campbell, Jalila Devji, Lívia Vieira Lopes, Rosa Balleny, Terteel Elawad, Rachel Craik, Marie‐Laure Volvert, Hiten D. Mistry, Hannah Blencowe, Véronique Filippi, Peter von Dadelszen, Laura A. Magee, Marianne Vidler, the PRECISE Network +16 morewiley +1 more sourceEffects of acute exposure to cadmiun on response to estrogen in the prepuberal rat uterus [PDF]
, 2008 Few information is available about uterine effects of Cadmium (Cd) exposure, where toxicagents affecting the female genital tract interact with estrogen (E) receptors, modifiying myometrial activityand the menstrual cycle, causing dysmenorrhea ...Bizjak, Tina, Villagra, Rebeca, Olivares, Francisca, Vera, Jeanette, Fernández Hidalgo, Juan, Iturbe, Ricardo J., Gaete González, Leonardo, Ferrada, Karla, Hernández, Natalia, Tchernitchin Varlamov, Andrés, Novsak, Spela, Aranda, Carlos, Bustamante Valdebenito, Rodrigo, Kim, Yoon A. +13 morecore Integrating Social and Clinical Determinants of Pre‐Eclampsia: A Hierarchical Systematic Review and Conceptual Framework for Prevention
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT Background
Pre‐eclampsia is a leading cause of maternal and perinatal morbidity and mortality, with risk factors reported across a vast literature base fragmented between social and clinical factors. Objective
To develop a comprehensive conceptual framework of the strongest risk factors and their relationships contributing to pre‐eclampsia ...Mai Lei Woo Kinshella, Jeffrey N. Bone, Terteel Elawad, Hiten D. Mistry, Laney Poye, Eleni Tsigas, Deepika Devadas, Violet Mateljan, Marie‐Laure Volvert, Marianne Vidler, Hannah Blencowe, Véronique Filippi, Laura A. Magee, Peter von Dadelszen, The PRECISE Network, Umberto D’Alessandro, Anna Roca, Hawanatu Jah, Andrew Prentice, Melisa Martinez‐Alvarez, Brahima Diallo, Abdul Sesay, Sambou Suso, Baboucarr Njie, Fatima Touray, Yahaya Idris, Fatoumata Kongira, Modou F. S. Ndure, Lawrence Gibba, Abdoulie Bah, Yorro Bah, Marleen Temmerman, Angela Koech, Patricia Okiro, Geoffrey Omuse, Grace Mwashigadi, Mary Goretti Amondi, Consolata Juma, Joseph Mutunga, Moses Mukhanya, Robin Okello, Onesmus Wanje, Isaac Mwaniki, Marvin Ochieng, Emily Mwadime, Esperança Sevene, Corssino Tchavana, Salesio Macuacua, Anifa Vala, Helena Boene, Lazaro Quimice, Sonia Maculuve, Inacio Mandomando, Peter von Dadelszen, Laura A. Magee, Rachel Craik, Marie‐Laure Volvert, Hiten Mistry, Thomas Mendy, Donna Russell, Prestige Tatenda Makanga, Liberty Makacha, Reason Mlambo, Lucilla Poston, Rachel Tribe, Sophie Moore, Tatiana Salisbury, Aris Papageorghiou, Alison Noble, Rachel Craik, Hannah Blencowe, Veronique Filippi, Joy Lawn, Matt Silver, Joseph Akuze, Ursula Gazeley, Judith Cartwright, Guy Whitley, Sanjeev Krishna, Marianne Vidler, Jing (Larry) Li, Jeff Bone, Mai‐Lei (Maggie) Woo Kinshella, Domena Tu, Ash Sandhu, Kelly Pickerill, Carla Carillho, Benjamin Barratt +87 morewiley +1 more sourceInternational Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema
Allergy, EarlyView.ABSTRACT
Hereditary angioedema (HAE) with C1 inhibitor deficiency is a rare disease characterized by unpredictable episodes of tissue swelling (angioedema), which, in most cases, occur first under the age of 18 years, and entail a significant burden of disease not only for the patients but also for their families.Henriette Farkas, Inmaculada Martinez‐Saguer, Konrad Bork, Anastasios E. Germenis, Anete S. Grumach, Hanga Réka Horváth, Andrea Luczay, Andrea Zanichelli, Markus Magerl, Stephen Betschel, Emel Aygören‐Pürsün, Jonathan A. Bernstein, Isabelle Boccon‐Gibod, Teresa Caballero, Mauro Cancian, Sandra Christiansen, Danny M. Cohn, Francisco Contreras, Sansanee Craig, Camelia Isaic, Ankur Jindal, Constance H. Katelaris, Hilary J. Longhurst, Andrew MacGinnitie, Jonny Peter, Grzegorz Porebski, Avner Reshef, Dinh Van Nguyen, Bruce Zuraw, Anthony J. Castaldo, Henrik Balle Boysen, Timothy Craig, the Hereditary Angioedema Working Group (HAWK Group), Adil Adatia, Fiorella Adrianzen, Shimalee Andarawewa, Sladjana Andrejevic, Gabriel Emmanuel Arce‐Estrada, Ecem Ay, Adil Bahadir, Noemi Anna Bara, Marko Barešić, Krasimira Baynova, Shira Benor, Juliette Besson, Dharmagat Bhattarai, Patricia Bigas, Alexis Bocquet, Laurence Bouillet, Nicholas Brodszki, Thomas Buttgereit, Rosario Cabañas, Regis Campos, Asuman Çamyar, Orlane Chol, Stefan Cimbollek, Monica Colque Bayona, Cascia Day, Mats de Lange, Alex Fam, Davide Firinu, Tomas Freiberger, Johana Gil‐Serrano, Delphine Gobert, Dawn Goodyear, Maria del Mar Guilarte Clavero, Svetlana Hadvabova, David Hagin, Roman Hakl, George Harmat, Mensuda Hasanhodzic, Gocki Jacek, Joshua Jacobs, Rashmi Jain, Milos Jesenak, Amin Kanani, Daniela Kapustová, Boris Karanovic, Paul Keith, Tamar Kinaciyan, Pavlina Kralickova, Marcin Kurowski, Krzysztof Kuziemski, Rolando Laurel‐Laurel, Iris Leibovich‐Nassi, Gabriela Leon Zambrana, Ramon Lleonart, Lorena Lorenzo, Ferhat Maksudov, Ania Manson, Dusanka Markovic, Jayne McGucken, Nihal Mete Gokmen, Radovan Mijanovic, Vania Maria Miranda Saavedra, Irene Modestou, Sandra Nieto, Nora Nilsson, Patrik Nordenfelt, Francesca Perego, Angelica Petraroli, Elsa Phillips‐Angles, Alicia Prieto‐García, Michel Raguet, Marc Riedl, Matija Rijavec, Solange Rodrigues Valle, Yaryna Romanyshyn, Antoine Saut, Riccardo Senter, Branislav Šlenker, Marta Sobotkova, Peter J. Spaeth, Marcin Stobiecki, Linda Sundler Björkman, Mireille‐Maria Suttle, Agnes Szilágyi, Paola Triggianese, Kassiani Tzeli, Martina Vachová, Anna Valerieva, Solange Valle, Lilian Varga, Walter A. Wuillemin, Patrick Yong, Zhi Yuxiang, Liudmyla Zabrodska, Radana Zachova, Julia Zharankova +128 morewiley +1 more sourceLongitudinal Follow‐Up of Gut and Salivary Microbiota in Children With Food Protein‐Induced Enterocolitis Syndrome
Allergy, EarlyView.This study aimed to compare both the gut and salivary microbiota over time between allergic and tolerant patients and matched controls. Allergic patients with food protein‐induced enterocolitis syndrome exhibited lower gut and salivary alpha‐diversities, several genus‐level differences, and higher acetate levels than controls.Anais Lemoine, Karine Adel‐Patient, Nathalie Kapel, Camille Mayeur, Marie‐Noelle Rossignol, Aurelia Bruneau, Patrick Tounian, Muriel Thomas, Ioannis Nicolis +8 morewiley +1 more sourceCardiovascular outcomes for Australian women with rheumatic heart disease during pregnancy: A retrospective linked data analysis, 2002–2017
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.This retrospective cohort study used linked data to measure the proportion of women with rheumatic heart disease (RHD) who experienced major adverse cardiovascular events (MACE) after 20 weeks of gestation. Before birth, 4.5% of women with initially uncomplicated RHD and 31.8% of women with initially complicated RHD experienced RHD‐MACE.Ingrid Stacey, Mohammed Junaid, Holger W. Unger, Geraldine Vaughan, Ye’elah Berman, Vicki Wade, Lee Nedkoff, James Marangou, Judith M. Katzenellenbogen +8 morewiley +1 more sourcePharmaceutical policy and off‐label prescribing in pregnancy: A population‐based historical cohort study analyzing inequality in access to antiemetics within Australia's Pharmaceutical Benefits Scheme
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.Public spending on antiemetics among pregnant women in Australia is concentrated in socioeconomically disadvantaged women. However, public expenditure is also driven by off‐label ondansetron use (i.e., use outside regulatory‐approved indications), highlighting a misalignment between pharmaceutical policy, public expenditure patterns, and pregnant women'Hannah Jackson, Luke Grzeskowiak, Joanne Enticott, Sarah Wise, Emily Callander +4 morewiley +1 more source